CXCR4 and neoplasm: Lindoso et al. described that MSCs treated with renal CSC-derived EVs were able to sustain tumor progression by enhancing MMP1, MMP2, MMP3, collagen 4A3, CXCR4 and CXCR7 expression levels, which results in increased tumor vascularization and proliferation [46].